Date | Operating Income Margin | EBT Margin | Net Income Margin | EBITDA Margin |
---|
CEO | Mr. Jitendra Rameshchandra Shah |
IPO Date | Oct. 27, 2016 |
Location | India |
Headquarters | Maas Heights |
Employees | 191 |
Sector | Health Care |
Industries |
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.
Past 5 years
USD 2.30
USD 3.83
USD 1.20
USD 1.16
USD 2.49
StockViz Staff
January 16, 2025
Any question? Send us an email